Roopa Industries

Roopa Industries Inventory

The Inventory of Roopa Industries (530991.BO) as of Nov 12, 2026 is 308.39 M INR. In the previous year, Inventory was 361.47 M INR — a change of -14.68% (lower).

Inventory

308.39 MINR

YoY

-14.68%

Last updated:

Inventory of Roopa Industries is 2026 308.39 M INR. Inventory of Roopa Industries was 2025 361.47 M INR. It decreases by -14.68% lower compared to the previous year.

The Roopa Industries Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
106.49 M INR
Jan 1, 2020
123.51 M INR
Jan 1, 2021
194.56 M INR
Jan 1, 2022
153.40 M INR
Jan 1, 2023
183.77 M INR
Jan 1, 2024
251.62 M INR
Jan 1, 2025
361.47 M INR
Jan 1, 2026
308.39 M INR
The Roopa Industries Inventory history
YEARInventoryYoY
308.39 MINR-14.68%
361.47 MINR+43.66%
251.62 MINR+36.93%
183.77 MINR+19.80%
153.40 MINR-21.15%
194.56 MINR+57.52%
123.51 MINR+15.99%
106.49 MINR+14.98%
92.62 MINR+30.29%
71.08 MINR+60.70%
44.23 MINR-44.96%
80.36 MINR+56.61%
51.31 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Roopa Industries Stock analysis

What does Roopa Industries do? Roopa Industries Ltd. manufactures pharmaceutical products, focusing on bulk drugs and drug intermediates. The company produces N,N-dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is used by manufacturers of Cephalosporin antibiotics and Statins, while Bromine And Its Derivatives serve agrochemicals, dyes, medical and veterinary products, water purification, and pesticides. Glucosamine is a key nutraceutical product. The primary buyers include pharmaceutical manufacturers, agrochemical companies, and producers of medical and veterinary compounds. The company's revenue streams come from the sale of these specialized chemical products to industries requiring bulk drugs and intermediates. Triphenyl Phosphine supports antibiotic and statin production, making it essential for pharmaceutical firms. Bromine And Its Derivatives cater to diverse sectors like agriculture, water treatment, and disinfection, with significant demand from agrochemical and medical product manufacturers. Glucosamine, as a sheet anchor product, drives sales in the nutraceutical market. Roopa Industries targets the pharmaceutical, agrochemical, and medical sectors with its product portfolio. The firm's focus on bulk drugs and intermediates positions it as a supplier to manufacturers of antibiotics, statins, and nutraceuticals. Its products are integral to the production of Cephalosporin group antibiotics, Statins, and various agrochemical applications, ensuring consistent demand from established industrial buyers. Roopa Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Roopa Industries stock

Inventory of Roopa Industries is 308.39 M INR in 2026.

Inventory of Roopa Industries changed from 361.47 M INR to 308.39 M INR, representing a -14.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Roopa Industries since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Roopa Industries historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Roopa Industries

All Key Metrics — Roopa Industries